Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-24-000100

President & CEO gave up 5,550 shares (to pay taxes)

  • President & CEO acquired 12,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Hirsch Andrew President & CEO 2024-11-07 Option exercise +12,500 227,412 D
Hirsch Andrew President & CEO 2024-11-07 Shares withheld for taxes −5,550 $6.04 $33,522 221,862 D
Derivatives
Hirsch Andrew President & CEO 2024-11-07 Option exercise · Performance Restricted Stock Units −12,500 35,000 D
Loading xslF345X05/wk-form4_1731446213.xml…